These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3128776)

  • 1. [Study of the expression of the interleukin 2 receptor on the lymphocytes of patients with multiple sclerosis using anti-Tac monoclonal antibodies].
    Selmaj K; Plater-Zyberk C; Rockett KA; Alam R; Maini RN; Perkin GD; Rose FC
    Pol Tyg Lek; 1987 Nov; 42(44):1389-91. PubMed ID: 3128776
    [No Abstract]   [Full Text] [Related]  

  • 2. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS; Calder VL; Feldmann M; Davison AN
    Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vivo T-lymphocyte activation in patients with multiple sclerosis].
    Tilbery CP; Atra M; Scheinberg MA
    Rev Paul Med; 1989; 107(3):167-8. PubMed ID: 2634877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of interleukin-2 receptor bearing lymphocytes in the skin. A comparative study of allergic and irritant contact dermatitis, tuberculin reaction and cutaneous T cell lymphoma.
    Klareskog L; Scheynius A; Tjernlund U
    Acta Derm Venereol; 1986; 66(3):193-9. PubMed ID: 2426894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
    Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
    J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.
    Van Wauwe JP; Goossens JG; Beverley PC
    J Immunol; 1984 Jul; 133(1):129-32. PubMed ID: 6327822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
    Hofman FM; von Hanwehr RI; Dinarello CA; Mizel SB; Hinton D; Merrill JE
    J Immunol; 1986 May; 136(9):3239-45. PubMed ID: 3082983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
    Palacios R
    J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
    J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the action and production of interleukin 2 (IL 2), expression of the IL 2 receptor and characterization of the immunologic phenotype of lymphocytes in the peripheral blood and lymph nodes of 51 patients with cancer of the larynx].
    Proto E; Coiana A; Macciò A; Manduco D; Mantovani G
    Acta Otorhinolaryngol Ital; 1987; 7(5):457-74. PubMed ID: 3126622
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
    Oudrhiri N; Farcet JP; Gourdin MF; Divine M; Bouguet J; Fradelizi D; Reyes F
    J Immunol; 1985 Sep; 135(3):1813-8. PubMed ID: 3926884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with anti-interleukin-2 receptor monoclonal antibody.
    Strom TB; Gaulton GN; Kelley VE; Diamanstein T; Kupiec-Weglinski J; Tilney NL; Kirkman RL
    Prog Clin Biol Res; 1986; 224():227-38. PubMed ID: 3099309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of OKT3 monoclonal antibodies and anti-TAC for the quantitative evaluation of interleukin-2].
    Cornaglia-Ferraris P; Baffico M
    Boll Ist Sieroter Milan; 1985; 64(6):471-4. PubMed ID: 3938289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Abnormal (constitutive) expression of interleukin 2 receptor (Tac Ag) in adult T-cell leukemia cells].
    Uchiyama T; Yodoi J; Maeda M
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):685-91. PubMed ID: 2985002
    [No Abstract]   [Full Text] [Related]  

  • 18. Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.
    Martin R
    Neurodegener Dis; 2008; 5(1):23-6. PubMed ID: 18075271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the expression of Tac antigen (T-cell growth factor response) on human thymocytes.
    Yeh NH; Dipre M; Reem GH
    Thymus; 1984; 6(4):255-61. PubMed ID: 6437022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
    Reed JC; Greene WC; Hoover RG; Nowell PC
    J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.